Stocktoria
BAXTER INTERNATIONAL INC BAX
NYSE · XNYS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 1961-05-15
BAXTER INTERNATIONAL INC financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $11.2B | $10.6B | $10.4B | $10.1B | $12.1B |
| Gross profit | $3.4B | $4.0B | $4.2B | $3.5B | $4.7B |
| R&D expense | $518.0M | $590.0M | $518.0M | $450.0M | $531.0M |
| SG&A expense | $2.9B | $3.0B | $3.0B | $3.1B | $2.8B |
| Operating income | -$308.0M | $14.0M | $707.0M | -$2.8B | $1.4B |
| Interest expense | $290.0M | $408.0M | $508.0M | $413.0M | $207.0M |
| Income tax | $395.0M | $37.0M | $61.0M | -$135.0M | $83.0M |
| Net income | -$957.0M | -$649.0M | $2.7B | -$2.4B | $1.3B |
| EPS (diluted) | $-1.87 | $-1.27 | $5.23 | $-4.83 | $2.53 |
| Operating cash flow | $951.0M | $1.0B | $1.7B | $1.2B | $2.2B |
| Cash & equivalents | $2.0B | $1.8B | $3.1B | $1.6B | $3.0B |
| Inventory | $2.2B | $2.0B | $1.9B | $2.7B | $2.5B |
| Total assets | $20.1B | $25.8B | $28.3B | $28.3B | $33.5B |
| Total liabilities | $14.0B | $18.8B | $19.8B | $22.4B | $24.4B |
| Shareholders' equity | $6.1B | $7.0B | $8.5B | $5.9B | $9.1B |
Source: SEC EDGAR filings · CIK 0000010456 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.